US FDA issues 5 observations to Dr Reddy’s plant in Hyderabad
The company has been issued a Form 483 Dr Reddy's Laboratories said the US health regulator has issued five observations after…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Dr Reddys launches anti-phlegm OTC drug in US market
OTC Guaifenesin and Pseudoephedrine HCl are used to help loosen phlegm (mucus) and thin bronchial secretions
Dr Reddy’s Laboratories plans to launch value-added drugs in US
Dr Reddy's Laboratories has said the company plans to launch several value-added products this fiscal to offset the persisting…
Budget reactions 2019
Union Budget 2019 evokes mixed reviews from the pharmaceutical industry
Satish Reddy, Chairman, Dr Reddy’s Laboratories
The…
Dr Reddy’s launches generic Hemabate injection in US market
Carboprost Tromethamine is used to treat severe bleeding after childbirth (postpartum) and is also used to produce an abortion by…
Dr Reddy’s launches in Phytonadione Injectable Emulsion USP in US market
Dr Reddy’s Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules is available in 1 mL Ampule containing 10 mg/mL of…
DRL launches Cefixime for oral suspension
The drug is a generic version of Suprax, approved by the US FDA
Dr Reddy’s to acquire Teva’s product portfolio for US Market
The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA. It also comprises complex generic…
DRL enters branded consumer health arena through acquisition of six OTC brands
DRL will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and…
Dr Reddy’s recalls 50k bottles of Ondansetron tabs in US
The ongoing recall was initiated on March 30, 2016